Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions
Viviane Maria de Carvalho Hessel Dias, Felipe Francisco Tuon, Patrícia de Jesus Capelo, et al.
Journal of Hospital Infection (2021) Vol. 120, pp. 43-47
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review
Usman Abubakar, Menier Al‐Anazi, Zainab alanazi, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 3, pp. 320-331
Open Access | Times Cited: 68
Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment
Huan-Yi Wu, Peng-Hao Chang, Kuan‐Yu Chen, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 55, Iss. 6, pp. 985-992
Open Access | Times Cited: 48
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review
Lucy S Witt, Jessica Howard‐Anderson, Jesse T. Jacob, et al.
JAC-Antimicrobial Resistance (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 35
A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence
Carlos Roberto Veiga Kiffer, Thaís Freitas Teles Rezende, Daniela Testoni, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_1, pp. S29-S37
Open Access | Times Cited: 17
Impact of the COVID-19 pandemic on multidrug-resistant hospital-acquired bacterial infections
Marco Bongiovanni, Giuseppe Barilaro, Umberto Zanini, et al.
Journal of Hospital Infection (2022) Vol. 123, pp. 191-192
Open Access | Times Cited: 23
Pseudomonas aeruginosa Bloodstream Infections in SARS-CoV-2 Infected Patients: A Systematic Review
Marco Bongiovanni, Beatrice Barda
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2252-2252
Open Access | Times Cited: 15
Rebound of Antibiotic Use and Respiratory Infections After Resumption of Normalcy From COVID-19 in Hong Kong
Edmond Siu-Keung, Enoch Hsu, Vincent Chow, et al.
Infection and Drug Resistance (2025) Vol. Volume 18, pp. 1325-1337
Open Access
Impact of COVID-19 on healthcare-associated infections: Antimicrobial consumption does not follow antimicrobial resistance
Maristela Pinheiro Freire, Denise Brandão de Assis, Bruno de Melo Tavares, et al.
Clinics (2023) Vol. 78, pp. 100231-100231
Open Access | Times Cited: 11
The impact of the COVID‐19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland
Mamoon A. Aldeyab, William Crowe, Reema Karasneh, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 9, pp. 2851-2866
Open Access | Times Cited: 10
Innovative Approaches to Monitor Central Line Associated Bloodstream Infections (CLABSIs) Bundle Efficacy in Intensive Care Unit (ICU): Role of Device Standardized Infection Rate (dSIR) and Standardized Utilization Ratio (SUR)—An Italian Experience
Silvia Boni, Marina Sartini, Filippo Del Puente, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 396-396
Open Access | Times Cited: 3
A scoping review of bacterial resistance among inpatients amidst the COVID-19 pandemic
Noora Reffat, Rebecca J. Schwei, M. Pamela Griffin, et al.
Journal of Global Antimicrobial Resistance (2024) Vol. 38, pp. 49-65
Open Access | Times Cited: 2
Bacterial co-infection in COVID-19: a call to stay vigilant
S Liu, Chao Yu, Qin Tu, et al.
PeerJ (2024) Vol. 12, pp. e18041-e18041
Open Access | Times Cited: 2
Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection
Jessica R. Sheldon, Lauren E. Himmel, Dillon E. Kunkle, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010809-e1010809
Open Access | Times Cited: 11
Antimicrobial Stewardship Programs: A Review of Strategies to Avoid Polymyxins and Carbapenems Misuse in Low Middle-Income Countries
Fabrício Rodrigues Torres de Carvalho, João Paulo Telles, Felipe Francisco Bodan Tuon, et al.
Antibiotics (2022) Vol. 11, Iss. 3, pp. 378-378
Open Access | Times Cited: 10
The impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospital.
Gökhan Metan, Mervenur Demir Çuha, Gülşen­ Hazırolan, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 17, pp. Doc15-Doc15
Closed Access | Times Cited: 10
Rising incidence of carbapenem resistant isolates: an Argentinian hospital’s experience. More trouble in the aftermath of the COVID-19 pandemic
Maximiliano Gabriel Castro, Lucía Ubiergo, Macarena Vicino, et al.
Iberoamerican Journal of Medicine (2022) Vol. 4, Iss. 2, pp. 92-99
Open Access | Times Cited: 9
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?
Adrian Brink, Guy A. Richards, Hafsah Deepa Tootla, et al.
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 6, pp. 595-604
Closed Access | Times Cited: 8
EXPRESS: Predictive Modeling of Mortality in Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections Using Machine Learning
Murat Özdede, Pınar Zarakolu, Gökhan Metan, et al.
Journal of Investigative Medicine (2024)
Closed Access | Times Cited: 1
Preliminary insights on carbapenem resistance in Enterobacteriaceae in high-income and low-/middle-income countries
Kornelia Stefaniak, Marcin Kiedrzyński, Ewa Korzeniewska, et al.
The Science of The Total Environment (2024) Vol. 957, pp. 177593-177593
Open Access | Times Cited: 1
The health facility as a risk factor for multidrug-resistant gram-negative bacteria in critically ill patients with COVID-19
Viviane de Macedo, Gabriela de Souza dos Santos, Rodolff Nunes da Silva, et al.
Clinics (2022) Vol. 77, pp. 100130-100130
Open Access | Times Cited: 7
Application of polyoxometalates and their composites for the degradation of antibiotics in water medium
Debasish Pal, Subhadeep Biswas, Ashish Kumar Nayak, et al.
Water Emerging Contaminants & Nanoplastics (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 3
Acinetobacter baumannii - The Rise of a Resistant Pathogen

IntechOpen eBooks (2023)
Open Access | Times Cited: 3
Impact of an antimicrobial stewardship program in a COVID-19 reference hospital according to the AWaRe classification
João Paulo Telles, Carolina Hikari Yamada, Thayrine Mayara Dario, et al.
American Journal of Infection Control (2022) Vol. 50, Iss. 10, pp. 1182-1184
Open Access | Times Cited: 4
Increasing community prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in urine is associated with increasing district-level antibiotic consumption
Larissa Hermann de Souza Nunes, Victoria Stadler Tasca Ribeiro, Rafael Buttini Salviato, et al.
FEMS Microbiology Letters (2024) Vol. 371
Closed Access
Persistent carbapenem resistance in mechanically ventilated ICU patients: A before-and-after analysis of the COVID-19 surge
Bianca Brandão de Paula Antunes, Leonardo dos Santos Lourenço Bastos, Pedro Kurtz, et al.
American Journal of Infection Control (2024)
Closed Access
Page 1 - Next Page

Scroll to top